What's new in aesthetics: August 2026

Welcome to the first monthly briefing from The Insider. Each month we will round up what is genuinely changing in aesthetics, minus the hype. Here is where things stand.

The regenerative wave keeps building

The clearest trend of the year continues: the shift from treatments that add or freeze towards treatments that aim to support the skin's own biology. Polynucleotides have led this wave and show no sign of slowing, with under eye treatments the most requested application in many UK clinics. Exosome treatments, typically applied alongside microneedling rather than injected, are the newer arrival generating buzz. As ever with the newest arrivals, enthusiasm is running ahead of long term evidence, so the sensible consumer questions are about a practitioner's specific product, protocol, and experience.

Combination protocols are becoming the norm

Clinics increasingly talk about plans rather than treatments: a skin booster course alongside a laser programme, or RF microneedling sequenced with injectables over several months. Done well, this reflects a genuinely more sophisticated approach to skin. Done cynically, it is a way to sell more. The difference usually shows in whether the plan starts from an honest assessment of your skin, includes the cheaper and slower options, and treats “not yet” as an acceptable answer.

Transparency is becoming a selling point

Perhaps the most encouraging shift: vetting and openness are turning into marketing assets. More consumers are asking about qualifications, insurance, and product sourcing before booking, and the better practitioners are responding by publishing exactly that information rather than treating it as an awkward question. Regulation of the UK aesthetics sector continues to move slowly, so for now, the burden of checking remains with the consumer. It should not be that way. Until it changes, informed consumers and transparent practitioners finding each other is the best version of this market, and it is precisely the gap LumyIQ exists to close.

One thing to watch

Keep an eye on the growing conversation around “prejuvenation” marketing aimed at ever younger audiences. Starting a considered skincare routine early is sensible. Being marketed injectable treatments in your late teens and early twenties on the basis of preventing lines that do not exist is something else, and the industry conversation about where that line sits is getting louder. Our view is simple: understanding your skin should always come before treating it, at any age.

See you next month. Until then: scan before any treatment.